Organon is a healthcare company whose health solutions, biosimilars and established brands aim to help women live better, healthier lives. Its U.S. product portfolio spans a range of therapeutic areas and includes prescription medicines, reproductive health products, inhalers, injectable treatments and other therapies. Featured products include the contraceptive options NEXPLANON, NuvaRing and MIUDELLA; fertility medicines such as FOLLISTIM AQ and Ganirelix Acetate Injection; and treatments such as HADLIMA, ONTRUZANT and RENFLEXIS. The portfolio also includes products for conditions involving respiratory health, bone health, allergies, cardiovascular health, skin and other areas.

Organon provides product websites and access to prescribing information, patient product information, medication guides and instructions for use. In the United States, patients and healthcare professionals can contact the Organon Service Center for product information, adverse-event reporting and product-quality complaints. The center also offers round-the-clock support for product-related emergencies, with regular weekday operating hours for other inquiries. Organon maintains healthcare professional resources through Organon Pro and directs visitors outside the United States to its worldwide locations for regional information.